Streetbeat News

Earnings

APCX

CHEK

NBSE

STOK

Stoke Therapeutics, Inc. (STOK) shares surged by approximately 70% in pre-market trading following the announcement of positive Phase 1/2a data for STK-001 in Dravet syndrome. Other stocks also showed significant movement in pre-market trading, with notable gainers including Check-Cap Ltd. (CHEK), C3is Inc. (CISS), and OpGen, Inc. (OPGN), among others. On the losing end, NeuBase Therapeutics, Inc. (NBSE) and AppTech Payments Corp. (APCX) saw substantial declines.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 12:00 pm

IAS

SIRI

The article highlights Sirius XM Holdings Inc. (SIRI) and Integral Ad Science Holding Corp. (IAS) as oversold stocks in the communications services sector, presenting them as potential investment opportunities. Sirius XM Holdings reported better-than-expected Q4 earnings, while Integral Ad Science Holding reported strong Q4 results with significant revenue growth. Both stocks have RSI values indicating they are oversold, suggesting potential for short-term performance improvement.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 11:58 am

MU

Micron Technology, Inc. (NASDAQ:MU) reported better-than-expected Q2 financial results and issued strong Q3 guidance, leading to a 6.3% increase in its stock price to $117.13. Analysts raised price targets following the earnings report. The company's dividend yield is 0.39%, equating to a quarterly dividend of 11.5 cents a share. To earn a monthly dividend income of $500, an investor would need to own approximately 13,043 shares, valued around $1,527,727.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 11:56 am

GDS

GDS Holdings reported a Q4 earnings per ADS of $(2.44), indicating a loss per ADS for the quarter.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:50 am

UPS

United Parcel Service Inc (NYSE:UPS) is experiencing a stock price increase due to its announcement of strategic growth and productivity initiatives, along with its three-year financial targets, at its investor and analyst conference. The company projects FY26 consolidated revenue of $108 billion to $114 billion, an adjusted operating margin above 13%, and a free cash flow of $17 billion to $18 billion. Despite a revenue decline in Q4 fiscal 2023, UPS shares are up 3.41% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

March 26, 2024 | 11:49 am

GDS

GDS Holdings reported Q4 sales of $360.10M, surpassing the analyst consensus estimate of $357.63M by 0.69% and marking a 3.31% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:48 am

ZH

Zhihu (NYSE:ZH) reported Q4 adjusted EPS losses of $(0.02), surpassing the $(0.04) estimate, and sales of $160.32M, exceeding the $148.11M estimate. This represents a 33.33% improvement in losses and a slight 0.73% decrease in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:43 am

MKC

McCormick & Company's shares saw an increase following the announcement of their Q1 financial results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:43 am

ZH

Zhihu reported Q4 sales of $160.32M, surpassing the $148.11M estimate, with an adjusted net loss of $12.9M. This indicates a stronger revenue performance than expected, though the company still operates at a loss.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:42 am

VRPX

Virpax Pharma (VRPX) reported a fiscal year 2023 earnings per share (EPS) loss of $(12.97), which is wider than the estimated loss of $(9.20). The company also reported a cash balance of $9.1 million.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 11:34 am